Interventions in the <font color="red">initial_2</font> <font color="red">prodromal_2</font> <font color="red">states_2</font> <font color="red">of_2</font> <font color="red">psychosis_2</font> <font color="red">in_1</font> <font color="red">Germany_2</font> <font color="red">:_2</font> concept and recruitment . 
<br>
<br> BACKGROUND The Early Detection and Intervention Programme of the German Research Network on <font color="red">Schizophrenia_1</font> ( GRNS ) investigates the <font color="red">initial_2</font> <font color="red">prodromal_2</font> <font color="red">phase_2</font> <font color="red">of_2</font> <font color="red">psychosis_2</font> in a multidimensional approach . Two intervention strategies are being studied by two large - scale multicentre projects . 
<br> AIMS To present the concept of the intervention studies , and to provide an interim report of the recruitment procedure . 
<br> METHOD Comprehensive cognitive - behavioural therapy has been developed for <font color="red">patients_1</font> <font color="red">in_1</font> <font color="red">the_1</font> <font color="red">"_1</font> <font color="red">early_2</font> <font color="red">initial_2</font> <font color="red">prodromal_2</font> <font color="red">state_2</font> <font color="red">"_2</font> <font color="red">._1</font> For <font color="red">patients_1</font> <font color="red">in_1</font> <font color="red">the_1</font> <font color="red">"_1</font> <font color="red">late_2</font> <font color="red">initial_2</font> <font color="red">prodromal_2</font> <font color="red">state_2</font> <font color="red">"_2</font> the atypical neuroleptic amisulpride is explored . Both interventions are evaluated in randomised controlled trials using clinical management as the control condition . 
<br> <font color="red">RESULTS_1</font> <font color="red">Between_1</font> <font color="red">January_1</font> <font color="red">2001_1</font> <font color="red">and_1</font> <font color="red">March_1</font> <font color="red">2003_1</font> <font color="red">,_1</font> <font color="red">1212_4</font> <font color="red">individuals_6</font> <font color="red">seeking_5</font> <font color="red">help_5</font> <font color="red">for_5</font> <font color="red">mental_5</font> <font color="red">health_5</font> <font color="red">problems_5</font> <font color="red">were_1</font> <font color="red">screened_1</font> <font color="red">for_1</font> <font color="red">putative_1</font> <font color="red">prodromal_1</font> symptoms at four university centres . <font color="red">More_3</font> <font color="red">than_3</font> <font color="red">388_6</font> <font color="red">individuals_6</font> <font color="red">fulfilled_6</font> <font color="red">criteria_6</font> <font color="red">for_5</font> <font color="red">both_5</font> <font color="red">interventions_5</font> <font color="red">and_5</font> <font color="red">188_5</font> <font color="red">(_5</font> <font color="red">48.5%_5</font> <font color="red">)_5</font> <font color="red">gave_5</font> <font color="red">informed_5</font> <font color="red">consent_5</font> <font color="red">to_5</font> <font color="red">participate_5</font> <font color="red">in_5</font> <font color="red">the_5</font> <font color="red">trials_5</font> <font color="red">._5</font> <font color="red">
<br>_2</font> CONCLUSIONS The screening procedure appears to be feasible and trial participation seems to be acceptable to a relevant proportion of people at increased risk of developing psychosis .